Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Disappointing results of pilot study of SDZ-PSC-833 + doxorubicin in colorectal cancer

Oct. 14, 1998

DepoTech and Chiron submit NDA for DepoCyt

Oct. 13, 1998

Matrix reports promising phase III results for IntraDose in breast cancer

Oct. 13, 1998

NCIC-CTG leads major international trial for new ovarian cancer compound

Oct. 13, 1998

Promising preclinical findings reported for PI-88; phase I testing begins next month

Oct. 13, 1998

Gene therapy targeting Tie2 receptor tyrosine kinase evaluated as antiangiogenic strategy

Oct. 13, 1998

Inex demonstrates effectiveness of new antisense drug

Oct. 13, 1998

New Zeneca facility to manufacture new cancer treatment

Oct. 9, 1998

Pivotal trial of exisulind for prostate cancer recurrence fully enrolled

Oct. 8, 1998

New orally active antitumor platinum complexes synthesized at SS Pharm.

Oct. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...